Editorials

Antenatal Hiv testing: what now?Despite guidelines, infections remain undetected

BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7092.1429 (Published 17 May 1997) Cite this as: BMJ 1997;314:1429

Despite guidelines, infections remain undetected

  1. Ahilya Noone, Consultant epidemiologist,
  2. David Goldberg, Consultant epidemiologist
  1. a Scottish Centre for Infection and Environmental Health, Ruchill Hospital, Glasgow G20 9NB

    If a pregnant woman has access to antiretroviral treatment she and her unborn child may benefit greatly from her knowledge of her HIV status early in pregnancy. Zidovudine given during pregnancy and to the infant has been shown to reduce the rate of vertical transmission from 25% to 8%.1 Furthermore, since antiretroviral therapy can produce impressive and sustained reductions in viral load, and low levels of circulating virus are associated with reduced vertical transmission2 as well as slower rates of disease progression,3 there is a strong case for early diagnosis. While mothers should always retain the right to decline an HIV test, every effort should be made to avoid undetected infection in pregnancy. To this end, the departments of health in the United Kingdom have recommended that obstetric units should offer an HIV test to all pregnant women (“universal testing”) in areas of high HIV prevalence4 5 and have provided guidance on how this should be done. Is this policy being implemented effectively?

    MacDonagh and colleagues recently reported on the effectiveness …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe